4-amino-N-methyl-N-[2-(methylamino)ethyl]benzamide | 1343927-36-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-amino-N-methyl-N-[2-(methylamino)ethyl]benzamide
• CAS: 1343927-36-5
• 化学式: C₁₁H₁₇N₃O
• 分子量: 207.275
• InChiKey: ULYJZIRPLLCKEL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  58.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  三光气 、 4-amino-N-methyl-N-[2-(methylamino)ethyl]benzamide 、 4-(4-methoxy-6-morpholino-1,3,5-triazin-2-yl)aniline 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 1.58h， 生成 4-({[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoyl}amino)-N-methyl-N-[2-(methylamino)ethyl]benzamide
  参考文献：
  名称：

  Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors

  摘要：

  We recently described several highly potent, triazine (1) and triazolopyrimidine (2) scaffold-based, dual PI3K/mTOR-inhibitors (e.g., 1, PKI-587) that were efficacious in both in vitro and in vivo models. In order to further optimize these compounds we devised a novel series, the 2-oxatriazines, which also exhibited excellent potency and good metabolic stability. Some 2-oxatriazines showed promising in vivo biomarker suppression and induced apoptosis in the MDA-MB-361 breast cancer xenograft model. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.06.063